 |
|
|
|||||
The markets are very nervous precisely because there is a lot of uncertainty and as we all know markets do not like uncertainty. And the new administration has provided plenty of it. So, what do we do in such situations?
Category:
News and Media
Canada's Minister of Foreign Affairs told the BBC's Newsnight her office had not been contacted about the plan.
Category:
News and Media
Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, enhancing its US oncology market presence. The company also got tentative approval for Rivaroxaban. Despite recent stock declines, analysts suggest a potential 22% upside. Biocon's Q3 profits dropped sharply due to a previous one-time gain.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||